Researchers have discovered that the enzyme ATP-citrate lyase (ACLY) plays a critical role in driving the inflammatory process linked to aging, known as the senescence-associated secretory phenotype (SASP). The study shows that blocking ACLY can reduce the expression of inflammation-related genes in aging cells, opening the door for potential therapies to combat age-related diseases like dementia and atherosclerosis.
You May Also Like
Why PTSD Develops in Some but Not Others
October 21, 2024
New Genes Linked to Muscle Aging Discovered
October 19, 2024
Enhancing AI Accuracy and Confidence in Answer Generation
October 19, 2024
More From Author
Why PTSD Develops in Some but Not Others
October 21, 2024
New Genes Linked to Muscle Aging Discovered
October 19, 2024
Listening to Music After Surgery Lowers Pain and Anxiety
October 19, 2024
+ There are no comments
Add yours